DOCSLIB.ORG

Annual Financial Report December 31, 2018

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Annual Financial Report December 31, 2018 ANNUAL FINANCIAL REPORT DECEMBER 31, 2018 DiaSorin S.p.A. Via Crescentino (no building No.) - 13040 Saluggia (VC) Tax I. D. and Vercelli Company Register no. 13144290155 1 WorldReginfo - 7c03bfce-0ba7-4e87-87f6-eb8b8820e180 TABLE OF CONTENTS REPORT ON OPERATIONS............................................................................................................................................................3 LETTER TO SHAREHOLDERS ......................................................................................................................................................3 BOARD OF DIRECTORS & CONTROL BODIES ...........................................................................................................................5 STRUCTURE OF THE GROUP AT DECEMBER 31, 2018 .............................................................................................................7 OUR BUSINESS ................................................................................................................................................................................8 RESEARCH AND DEVELOPMENT.............................................................................................................................................. 10 FOCUS ON OUR PLATFORMS ................................................................................................................................................ 10 FOCUS ON MOLECULAR DIAGNOSTICS............................................................................................................................. 11 RESEARCH AND DEVELOPMENT COSTS AND INVESTMENTS ...................................................................................... 13 PUTTING PEOPLE AT THE HEARTH .......................................................................................................................................... 14 STOCK OWNERSHIP ..................................................................................................................................................................... 15 HIGHLIGHTS.................................................................................................................................................................................. 17 REVIEW OF THE GROUP’S OPERATING PERFORMANCE AND FINANCIAL POSITION ................................................... 22 NON-RECURRING MATERIAL TRANSACTIONS AND ATYPICAL AND/OR UNUSUAL TRANSACTIONS ..................... 30 MAIN RISKS AND UNCERTAINTIES TO WHICH DIASORIN S.P.A. AND THE GROUP ARE EXPOSED ............................ 31 SIGNIFICANT EVENTS OCCURRING AFTER DECEMBER 31, 2018 AND BUSINESS OUTLOOK .................................... 33 REVIEW OF THE OPERATING PERFORMANCE AND FINANCIAL POSITION OF DIASORIN S.P.A. .............................. 34 RELATED-PARTY TRANSACTIONS .......................................................................................................................................... 41 REPORT ON CORPORATE GOVERNANCE AND OWNERSHIP STRUCTURE ....................................................................... 42 CONSOLIDATED NON-FINANCIAL DISCLOSURE AT DECEMBER 31, 2018 ..................................................................... 84 INDEPENDENT REPORT ON THE LIMITED AUDIT OF THE CONSOLIDATED NON-FINANCIAL STATEMENTS OF THE DIASORIN GROUP ................................................................................................................................................................ 127 MOTION TO APPROVE THE FINANCIAL STATEMENTS AND APPROPRIATE THE 2018 NET PROFIT ........................ 131 CONSOLIDATED FINANCIAL STATEMENTS AT DECEMBER 31, 2018 AND DECEMBER 31, 2017 OF THE DIASORIN GROUP ............................................................................................................................................................................................ 132 ANNEX I: LIST OF EQUITY INVESTMENTS WITH THE SUPPLEMENTAL DISCLOSURES REQUIRED BY CONSOB COMMUNICATION NO. DEM/6064293 ....................................................................................................................................... 189 ANNEX II: DISCLOSURE REQUIRED PURSUANT TO ARTICLE 149-DUODECIES OF THE CONSOB ISSUERS’ REGULATIONS .............................................................................................................................................................................. 191 CERTIFICATION OF THE STATUTORY FINANCIAL STATEMENTS ................................................................................. 192 STATUTORY FINANCIAL STATEMENTS OF DIASORIN S.P.A. AT DECEMBER 31, 2018 AND AT DECEMBER 31, 2017 .......................................................................................................................................................................................................... 193 ANNEX III: DISCLOSURE REQUIRED PURSUANT TO ARTICLE 149-DUODECIES OF THE CONSOB’S ISSUERS’ REGULATIONS .............................................................................................................................................................................. 251 CERTIFICATION OF THE STATUTORY FINANCIAL STATEMENTS PURSUANT TO ARTICLE 81-TER OF CONSOB REGULATION NO. 11971 OF MAY 14, 1999, AS AMENDED ................................................................................................... 252 REPORT OF THE BOARD OF STATUTORY AUDITORS 253 INDEPENDENT AUDITOR’S REPORT………………...………………………………………………………………………270 2 WorldReginfo - 7c03bfce-0ba7-4e87-87f6-eb8b8820e180 REPORT ON OPERATIONS LETTER TO SHAREHOLDERS Dear Shareholders, the year 2018 confirmed DiaSorin’s excellent financial results, with increased revenues and profitability along with record net profit and cash generation. We undertook several projects as evidence of our ongoing quest for cutting-edge, reliable products, in order to provide our customers - the diagnostic laboratories- with more effective solutions capable of delivering high-quality and swift answers. Our customers have always been at the hearth of every single initiative and decision related to investment and development, as regards both the consolidated immunodiagnostics framework and the recent molecular diagnostics segment. The year 2018 continued to confirm DiaSorin as the immunodiagnostic Company with the broadest specialty menu available on the global market with over 115 products, including 30 high-specialty tests. We kept on expanding the number of molecular diagnostic tests by launching 4 new kits and 11 new ASRs, increasing our already extensive menu available on LIAISON MDX and laying the foundation for further business growth. It is noteworthy to mention the launch of latent tuberculosis test, following the agreement with QIAGEN on the use of QuantiFERON technology. This diagnostic specialty offers strong growth prospects for both companies, given the spread of Tuberculosis around the world. Furthermore, the successful development of this test opened the way for new diagnostic applications generated by synergy among technologies. The success of LIAISON analyzers placements continued, with an overall installed base exceeding 7,800 units, with LIAISON XL representing more than 50% of analyzers. During the year, we continue to focus on the development of the new LIAISON XS: the analyzer will be launched on the European market in first month of 2019 to serve small-medium sized laboratories. In 2018, we worked on business development, through an important agreement signed with MERIDIAN BIOSCIENCE, a major U.S. diagnostics company, to sell DiaSorin’s FDA-cleared H. Pylori stool antigen test to detect Helicobacter Pylori for use on its automated LIAISON platform. In light of the above, I believe that DiaSorin, once again, represents the excellence standard in the diagnostic sector at global level, laying the foundation for further success to be achieved in the forthcoming years. This success stems from our vision, strategy, passion, ability to adapt to changing market conditions, as well as a corporate talent-oriented culture, which is a necessary and essential condition for an innovative and fast- growing company like DiaSorin. 3 WorldReginfo - 7c03bfce-0ba7-4e87-87f6-eb8b8820e180 I would like to thank our Top Management, all employees and Shareholders for confirming their trust in the Group’s important objectives that are intended to drive our Company towards important results. And, I would also like to mention our commitment to corporate sustainability initiatives that, again this year, have been at the basis of our conduct, especially with respect to local communities where we operate. Our projects range from those to support talent and love for science, like Mad for Science, to those to help athletes facing difficult situations, like Talent Project with FISIP or DiaSorin Sitting Volley Cup, or those to ease hospitalized children’s anxieties, like Pinocchio Project…small acts demonstrating how focus on Individuals has become increasingly important to build up a better future for our Society. Gustavo Denegri Chairman 4 WorldReginfo - 7c03bfce-0ba7-4e87-87f6-eb8b8820e180 BOARD OF DIRECTORS & CONTROL BODIES BOARD OF DIRECTORS (appointed on April 28, 2016) Chairman Gustavo Denegri Deputy Chairman Michele Denegri Chief Executive Officer Carlo Rosa (1) Directors Giancarlo Boschetti Stefano Altara Chen Menachem Even Franco Moscetti (2) Giuseppe Alessandria (2) (3) Roberta Somati (2) Fiorella Altruda (2) (4) Francesca Pasinelli (2) Monica Tardivo
Load more

Recommended publications
  • Impatto COVID-19 Sui Primi Nove Mesi 2020 (Mnes Mondiali E FTSE MIB)
    BRIEFING NOTE: IMPACTS OF COVID-19 PANDEMIC ON 9 MONTHS 2020 (MNES AND FTSE MIB) Area Studi Mediobanca Milan, 19 November 2020 1 ASM SHEDS LIGHT ON THE IMPACT OF PANDEMIC FOR 9M 2020 The survey analyses trends on results for 9M 2020 of: 1) Large industrial companies that have disclosed the results for the period January- September by November 16, 2020, sector by sector 2) 26 industrial and service companies listed on the FTSE MIB*: A2A, Amplifon, Atlantia, Buzzi Unicem, CNH Industrial, Davide Campari-Milano, DiaSorin, ENEL, ENI, FCA, Ferrari, Hera, Interpump Group, Inwit, Italgas, Leonardo, Moncler, Pirelli & C., Prysmian, Recordati, Saipem, Snam, STM, Telecom Italia, Tenaris, Terna That are 15 privately held and 11 state-owned companies, 16 manufacturing industry, 6 energy/utilities, 3 service companies and 1 oil and gas At the end of September 2020 the FTSE MIB companies analyzed were worth 318 €billion on the stock market and represented 76% of the total capitalization (excluding finance and insurance) 2 * Escluding Exor because does not publish quarterly reports SUMMARY 1. Impact on results for 9M 2020: Large industrial companies 2. Impact on results for 9M 2020: FTSE MIB (industry and services) 3. Overall look 3 IMPACT ON RESULTS FOR 9M 2020: LARGE INDUSTRIAL COMPANIES Section 1 4 REVENUES GROWTH IN 9M 2020/2019 Net sales 9M 2020/2019, percentage change – Multinational companies by sectors 18.4 8.8 5.7 3.7 3.1 0.3 -1.8 -5.4 -9.4 -17.4 -21.3 -30.6 -32.3 The world multinational companies average is equal to: -4.3% 5 REVENUES GROWTH IN DIFFERENT QUARTERS 2020 Net sales 9M 2020/2019, percentage change - Multinational companies by sectors 1Q 2020/2019 2Q 2020/2019 3Q 2020/2019 20.4 17.3 17.5 10.5 7.3 8.5 6.5 5.9 6.3 5.5 4.5 3.8 5.0 4.6 4.3 2.4 2.2 -0.2 -1.6 -0.8 -2.3 -2.5 -3.2 -3.0 -5.7 -9.2 -8.7 -9.8 -12.5 -13.1 -14.8 -21.7 -21.9 -28.0 -31.6 -40.5 -41.6 -42.1 -51.5 WebSoft, large-scale distribution, electronics and food are the only sectors to grow the net sales in all the different quarters of 2020.
    [Show full text]
  • Report on Remuneration Policy and Compensation Paid 2021
    Report on theremuneration Remuneration policy Policyand compensation and remuneration paid paid 2021 energy to inspire the world COMPANY PROFILE Snam is one of the world’s leading energy infrastructure operators and ranks among Italy’s largest listed companies, by market capitalization. Through a sustainable and technologically advanced network, Snam guarantees the security of supply and is a key enabler in the energy transition. Through its international footprint Snam operates in Albania (AGSCo), Austria (TAG, GCA), France (Teréga), Greece (DESFA), Italy, UAE (ADNOC Gas Pipelines) and UK (Interconnector UK) and has recently started activities in China and India. Snam is also one of the leading shareholders in TAP (Trans Adriatic Pipeline). The Group has the largest natural gas transportation network (over 41,000 km including international assets) and storage capacity (approx. 20 bcm including international assets) among its European peers and is also a leading player in regasification, through the LNG terminal in Panigaglia (GNL Italia) and its stakes in the Livorno (OLT) and Rovigo (Adriatic LNG) terminals in Italy and in the Revithoussa (DESFA) terminal in Greece. In its 2020-2024 strategic plan, Snam plans an increase in investments to 7.4 billion euros and more focus on the energy transition businesses: biomethane (Snam4Environment), energy efficiency (Renovit), sustainable mobility (Snam4Mobility) and hydrogen. The company also operates in forestation (Arbolia) and is committed to achieving carbon neutrality (Scope 1 and Scope 2) by 2040. The Group’s business model is based on sustainable growth, transparency, the promotion of talents and diversity and the social development of local areas also through the initiatives of Fondazione Snam.
    [Show full text]
  • Full Portfolio Holdings
    Hartford Multifactor International Fund Full Portfolio Holdings* as of August 31, 2021 % of Security Coupon Maturity Shares/Par Market Value Net Assets Merck KGaA 0.000 152 36,115 0.982 Kuehne + Nagel International AG 0.000 96 35,085 0.954 Novo Nordisk A/S 0.000 333 33,337 0.906 Koninklijke Ahold Delhaize N.V. 0.000 938 31,646 0.860 Investor AB 0.000 1,268 30,329 0.824 Roche Holding AG 0.000 74 29,715 0.808 WM Morrison Supermarkets plc 0.000 6,781 26,972 0.733 Wesfarmers Ltd. 0.000 577 25,201 0.685 Bouygues S.A. 0.000 595 24,915 0.677 Swisscom AG 0.000 42 24,651 0.670 Loblaw Cos., Ltd. 0.000 347 24,448 0.665 Mineral Resources Ltd. 0.000 596 23,709 0.644 Royal Bank of Canada 0.000 228 23,421 0.637 Bridgestone Corp. 0.000 500 23,017 0.626 BlueScope Steel Ltd. 0.000 1,255 22,944 0.624 Yangzijiang Shipbuilding Holdings Ltd. 0.000 18,600 22,650 0.616 BCE, Inc. 0.000 427 22,270 0.605 Fortescue Metals Group Ltd. 0.000 1,440 21,953 0.597 NN Group N.V. 0.000 411 21,320 0.579 Electricite de France S.A. 0.000 1,560 21,157 0.575 Royal Mail plc 0.000 3,051 20,780 0.565 Sonic Healthcare Ltd. 0.000 643 20,357 0.553 Rio Tinto plc 0.000 271 20,050 0.545 Coloplast A/S 0.000 113 19,578 0.532 Admiral Group plc 0.000 394 19,576 0.532 Swiss Life Holding AG 0.000 37 19,285 0.524 Dexus 0.000 2,432 18,926 0.514 Kesko Oyj 0.000 457 18,910 0.514 Woolworths Group Ltd.
    [Show full text]
  • Wilmington Funds Holdings Template DRAFT
    Wilmington Global Alpha Equities Fund as of 5/31/2021 (Portfolio composition is subject to change) ISSUER NAME % OF ASSETS USD/CAD FWD 20210616 00050 3.16% DREYFUS GOVT CASH MGMT-I 2.91% MORGAN STANLEY FUTURE USD SECURED - TOTAL EQUITY 2.81% USD/EUR FWD 20210616 00050 1.69% MICROSOFT CORP 1.62% USD/GBP FWD 20210616 49 1.40% USD/JPY FWD 20210616 00050 1.34% APPLE INC 1.25% AMAZON.COM INC 1.20% ALPHABET INC 1.03% CANADIAN NATIONAL RAILWAY CO 0.99% AIA GROUP LTD 0.98% NOVARTIS AG 0.98% TENCENT HOLDINGS LTD 0.91% INTACT FINANCIAL CORP 0.91% CHARLES SCHWAB CORP/THE 0.91% FACEBOOK INC 0.84% FORTIVE CORP 0.81% BRENNTAG SE 0.77% COPART INC 0.75% CONSTELLATION SOFTWARE INC/CANADA 0.70% UNITEDHEALTH GROUP INC 0.70% AXA SA 0.63% FIDELITY NATIONAL INFORMATION SERVICES INC 0.63% BERKSHIRE HATHAWAY INC 0.62% PFIZER INC 0.62% TOTAL SE 0.61% MEDICAL PROPERTIES TRUST INC 0.61% VINCI SA 0.60% COMPASS GROUP PLC 0.60% KDDI CORP 0.60% BAE SYSTEMS PLC 0.57% MOTOROLA SOLUTIONS INC 0.57% NATIONAL GRID PLC 0.56% PUBLIC STORAGE 0.56% NVR INC 0.53% AMERICAN TOWER CORP 0.53% MEDTRONIC PLC 0.51% PROGRESSIVE CORP/THE 0.50% DANAHER CORP 0.50% MARKEL CORP 0.49% JOHNSON & JOHNSON 0.48% BUREAU VERITAS SA 0.48% NESTLE SA 0.47% MARSH & MCLENNAN COS INC 0.46% ALIBABA GROUP HOLDING LTD 0.45% LOCKHEED MARTIN CORP 0.45% ALPHABET INC 0.44% MERCK & CO INC 0.43% CINTAS CORP 0.42% EXPEDITORS INTERNATIONAL OF WASHINGTON INC 0.41% MCDONALD'S CORP 0.41% RIO TINTO PLC 0.41% IDEX CORP 0.40% DIAGEO PLC 0.40% LENNOX INTERNATIONAL INC 0.40% PNC FINANCIAL SERVICES GROUP INC/THE 0.40% ACCENTURE
    [Show full text]
  • Fondo Pensione Aperto Unipolsai Previdenza FPA Bilancio
    2020 Fondo Pensione Aperto UnipolSai Previdenza FPA Bilancio Progetto Grafico Mercurio GP Srl Sede Legale: Via Stalingrado 45 – 40128 Bologna (Italia) Capitale sociale € 2.031.456.338,00 interamente versato Registro delle imprese di Bologna, C.F. 00818570012 – P.IVA 03740811207 – R.E.A. n. 511469 Società soggetta all’attività di direzione e coordinamento di Unipol Gruppo S.p.A., iscritta all’ Albo Imprese di Assicurazione e riassicurazione Sez. I al n.1.00006 e facente parte del Gruppo Assicurativo Unipol Iscritto all’Albo delle società capogruppo al n. 046 Bilancio 2020 del Fondo Pensione Aperto UnipolSai Previdenza FPA INDICE Relazione sulla gestione 7 Nota Integrativa – Informazioni generali 41 Comparto Garantito Flex Rendiconto della fase di accumulo 47 Comparto Obbligazionario Rendiconto della fase di accumulo 59 Comparto Bilanciato Etico Rendiconto della fase di accumulo 71 Comparto Bilanciato Prudente Rendiconto della fase di accumulo 85 Comparto Bilanciato Equilibrato Rendiconto della fase di accumulo 103 Comparto Bilanciato Dinamico Rendiconto della fase di accumulo 121 Comparto Azionario Rendiconto della fase di accumulo 139 Relazioni della Società di Revisione 157 UnipolSai Previdenza FPA Fondo pensione aperto a contribuzione definita Relazione sulla gestione 7 Situazione del Fondo al 31 dicembre 2020 Il Fondo Pensione Aperto UnipolSai Previdenza FPA (di seguito anche il "Fondo" o il "Fondo Pensione") ha proseguito, nel corso del 2020, la raccolta delle adesioni iniziata il 14 aprile 1999. Alla fine dell’esercizio il patrimonio complessivo netto del Fondo ammonta a 863.240.092,51 Euro, ripartiti su sette linee di investimento. Situazione previdenziale del fondo Al 31 dicembre 2020 risultano iscritti al Fondo n° 40.235 soggetti attivi, di cui n° 15.841 lavoratori che hanno aderito su base contrattuale collettiva in ragione di specifici accordi e n° 24.394 lavoratori che hanno aderito su base individuale.
    [Show full text]
  • Vanguard Total World Stock Index Fund Annual Report October 31, 2020
    Annual Report | October 31, 2020 Vanguard Total World Stock Index Fund See the inside front cover for important information about access to your fund’s annual and semiannual shareholder reports. Important information about access to shareholder reports Beginning on January 1, 2021, as permitted by regulations adopted by the Securities and Exchange Commission, paper copies of your fund’s annual and semiannual shareholder reports will no longer be sent to you by mail, unless you specifically request them. Instead, you will be notified by mail each time a report is posted on the website and will be provided with a link to access the report. If you have already elected to receive shareholder reports electronically, you will not be affected by this change and do not need to take any action. You may elect to receive shareholder reports and other communications from the fund electronically by contacting your financial intermediary (such as a broker-dealer or bank) or, if you invest directly with the fund, by calling Vanguard at one of the phone numbers on the back cover of this report or by logging on to vanguard.com. You may elect to receive paper copies of all future shareholder reports free of charge. If you invest through a financial intermediary, you can contact the intermediary to request that you continue to receive paper copies. If you invest directly with the fund, you can call Vanguard at one of the phone numbers on the back cover of this report or log on to vanguard.com. Your election to receive paper copies will apply to all the funds you hold through an intermediary or directly with Vanguard.
    [Show full text]
  • FTSE MIB Quarterly Rebalancing Changes 15 March 2021 FTSE MIB
    FTSE MIB Quarterly Rebalancing Changes 15 March 2021 FTSE Russell announces the new shares number and Investability Weighting Factors for the FTSE MIB Index effective after the close of business on Friday, 19 March 2021, i.e. on Monday, 22 March 2021. According to the FTSE MIB Ground Rules art. 7.4 and Appendix C, FTSE publishes share in issue & IWF figures updated at the cut-off date, where needed adjusted for capping based on capitalisation calculated with closing prices of five trading days before the rebalancing. The share in issue figure excludes all treasury shares and the Investability Weighting is computed with reference to shares in issue net of treasury shares. The new index divisor will be published after close of business on Friday, 19 March 2021. FTSE MIB Ribilanciamento trimestrale 15 marzo 2021 FTSE Russell comunica il nuovo numero di azioni e i pesi di investibilità per l'Indice FTSE MIB che saranno effettivi dopo la chiusura delle contrattazioni di venerdì 19 marzo 2021 (vale a dire da lunedì 22 marzo 2021). Secondo le Regole di base del FTSE MIB art. 7.4 e l'Appendice C, sono indicati i valori del numero di azioni e peso di investibilità aggiornati alla data del cut-off, eventualmente soggetti alla correzione del capping applicata con riferimento alle capitalizzazioni calcolate con i prezzi di chiusura di cinque giorni di negoziazione prima della data di ribilanciamento. Il numero di azioni esclude tutte le azioni proprie e la percentuale di flottante è calcolata con riferimento al numero di azioni al netto delle azioni proprie.
    [Show full text]
  • FTSE MIB Quarterly Rebalancing Changes 16 September 2019 FTSE
    FTSE MIB Quarterly Rebalancing Changes 16 September 2019 FTSE announces the new shares number and Investability Weighting Factors for the FTSE MIB Index effective after the close of business on Friday, 20 September 2019, i.e. on Monday, 23 September 2019. According to the FTSE MIB Ground Rules art. 7.4 and Appendix C, FTSE publishes share in issue & IWF figures updated at the cut-off date, where needed adjusted for capping based on capitalisation calculated with closing prices of five trading days before the rebalancing. The share in issue figure excludes all treasury shares and the Investability Weighting is computed with reference to shares in issue net of treasury shares. The new index divisor will be published after close of business on Friday, 20 September 2019. FTSE MIB Ribilanciamento trimestrale 16 settembre 2019 FTSE comunica il nuovo numero di azioni e i pesi di investibilità per l'Indice FTSE MIB che saranno effettivi dopo la chiusura delle contrattazioni di venerdì 20 settembre 2019 (vale a dire da lunedì 23 settembre 2019). Secondo le Regole di base del FTSE MIB art. 7.4 e l'Appendice C, sono indicati i valori del numero di azioni e peso di investibilità aggiornati alla data del cut-off, eventualmente soggetti alla correzione del capping applicata con riferimento alle capitalizzazioni calcolate con i prezzi di chiusura di cinque giorni di negoziazione prima della data di ribilanciamento. Il numero di azioni esclude tutte le azioni proprie e la percentuale di flottante è calcolata con riferimento al numero di azioni al netto delle azioni proprie. Il nuovo divisor per il FTSE MIB sarà reso disponibile dopo la chiusura delle contrattazioni di venerdì 20 settembre 2019.
    [Show full text]
  • Appendix D - Securities Held by Funds October 18, 2017 Annual Report of Activities Pursuant to Act 44 of 2010 October 18, 2017
    Report of Activities Pursuant to Act 44 of 2010 Appendix D - Securities Held by Funds October 18, 2017 Annual Report of Activities Pursuant to Act 44 of 2010 October 18, 2017 Appendix D: Securities Held by Funds The Four Funds hold thousands of publicly and privately traded securities. Act 44 directs the Four Funds to publish “a list of all publicly traded securities held by the public fund.” For consistency in presenting the data, a list of all holdings of the Four Funds is obtained from Pennsylvania Treasury Department. The list includes privately held securities. Some privately held securities lacked certain data fields to facilitate removal from the list. To avoid incomplete removal of privately held securities or erroneous removal of publicly traded securities from the list, the Four Funds have chosen to report all publicly and privately traded securities. The list below presents the securities held by the Four Funds as of June 30, 2017. 1345 AVENUE OF THE A 1 A3 144A AAREAL BANK AG ABRY MEZZANINE PARTNERS LP 1721 N FRONT STREET HOLDINGS AARON'S INC ABRY PARTNERS V LP 1-800-FLOWERS.COM INC AASET 2017-1 TRUST 1A C 144A ABRY PARTNERS VI L P 198 INVERNESS DRIVE WEST ABACUS PROPERTY GROUP ABRY PARTNERS VII L P 1MDB GLOBAL INVESTMENTS L ABAXIS INC ABRY PARTNERS VIII LP REGS ABB CONCISE 6/16 TL ABRY SENIOR EQUITY II LP 1ST SOURCE CORP ABB LTD ABS CAPITAL PARTNERS II LP 200 INVERNESS DRIVE WEST ABBOTT LABORATORIES ABS CAPITAL PARTNERS IV LP 21ST CENTURY FOX AMERICA INC ABBOTT LABORATORIES ABS CAPITAL PARTNERS V LP 21ST CENTURY ONCOLOGY 4/15
    [Show full text]
  • Vanguard FTSE International Index Funds Annual
    Annual Report | October 31, 2020 Vanguard FTSE International Index Funds Vanguard FTSE All-World ex-US Index Fund Vanguard FTSE All-World ex-US Small-Cap Index Fund See the inside front cover for important information about access to your fund’s annual and semiannual shareholder reports. Important information about access to shareholder reports Beginning on January 1, 2021, as permitted by regulations adopted by the Securities and Exchange Commission, paper copies of your fund’s annual and semiannual shareholder reports will no longer be sent to you by mail, unless you specifically request them. Instead, you will be notified by mail each time a report is posted on the website and will be provided with a link to access the report. If you have already elected to receive shareholder reports electronically, you will not be affected by this change and do not need to take any action. You may elect to receive shareholder reports and other communications from the fund electronically by contacting your financial intermediary (such as a broker-dealer or bank) or, if you invest directly with the fund, by calling Vanguard at one of the phone numbers on the back cover of this report or by logging on to vanguard.com. You may elect to receive paper copies of all future shareholder reports free of charge. If you invest through a financial intermediary, you can contact the intermediary to request that you continue to receive paper copies. If you invest directly with the fund, you can call Vanguard at one of the phone numbers on the back cover of this report or log on to vanguard.com.
    [Show full text]
  • Effects of Covid-19 on 9M 2020 Results
    EFFECTS OF COVID -19 ON 9M 2020 RESULTS FOR MULTINATIONALS A ND FTSE MIB COMPANIES MULTINAT IONAL S: SOFTWARE /INTERNET , LARGE -SCALE DISTRIBUTION A ND ELECTRONICS CONTINUE TO GROW ; OIL /GAS , FASHION AND A UTOMOTIVE STRUGGLING FTSE MIB COMPANIES : €46 BN IN MARKET CAP WIPED OFF THE STOCK MARKET IN 9M, SOME OF WHICH HAS BEEN RECOVERED ALREADY ; POSITIVE RESPONSE FR OM MANUFACTURING INDUST RY IN 3Q Milan, 19 November 2020 The Mediobanca Research Area has analysed the impact of the Covid-19 pandemic on the 9M 2020 financial statements of over 160 global industrial multinationals with annual turnover of more than €3bn, and the 26 industrial and services companies included in the FTSE MIB index. 1 The presentation is available for download from the company’s website at www.mbres.it. ****** Industrial multinationals in 9M 2020: comparison between sectors In the first nine months of 2020, the turnover posted by the industrial multinationals analysed shrank by 4.3% Y.o.Y., with the reductions by certain sectors offset in part by the growth in others. Software/internet, large-scale distribution, electronics and food are the only sectors that saw total sales increase in all the first three quarters of 2020. In particular, top-line growth was reported by the software/internet companies (total sales up 18.4% Y.o.Y.), followed by large-scale distribution (up 8.8%) and electronics (up 5.7%). Other good performances were reported by the food multinationals (total sales up 3.7%), the pharmaceutical companies (up 3.1%) and the firms operating in the pay tech industry (up 0.3%).
    [Show full text]
  • Prospectus Initial Public Offering of Shares in Lumos Diagnostics Holdings Limited ACN 630 476 970
    prospectus Initial public offering of shares in Lumos Diagnostics Holdings Limited ACN 630 476 970 Joint Lead Managers and Underwriter Australian Legal Adviser Financial adviser B Important Notices The Offer investors are set out in Section 5. There may be risk factors in addition to these that should be considered in light of your personal The Offer contained in this Prospectus is an invitation for you to apply circumstances. for fully paid ordinary shares (Shares) in Lumos Diagnostics Holdings Limited ACN 630 476 970 (the Company or Lumos). This Prospectus You should also consider the assumptions underlying the Forecast is issued by the Company and Lumos Diagnostics SaleCo Limited Financial Information set out in Section 4 and the risk factors set out ACN 650 279 511 (SaleCo). See Section 7.1 for further information on in Section 5 that could affect Lumos’ business, financial condition and the Offer, including as to details of the securities that will be issued results of operations. and transferred under this Prospectus. No person named in this Prospectus, nor any other person, Lodgement and Listing guarantees the performance of Lumos, the repayment of capital by Lumos or the payment of a return on the Shares. This Prospectus is dated Monday, 7 June 2021 and copy was lodged with the Australian Securities and Investments Commission (ASIC) on No person is authorised to give any information or make any that date (Prospectus Date). representation in connection with the Offer which is not contained in this Prospectus. Any information or representation not so contained Lumos will apply to the ASX within seven days after the Prospectus may not be relied on as having been authorised by Lumos or SaleCo, Date for admission of the Company to the Official List and quotation any of either of their Directors, officers, employees, advisers, agents, of the Shares on the ASX (Listing).
    [Show full text]